ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,961, issued on Aug. 19, was assigned to Factor Bioscience Inc. (Cambridge, Mass.).
"Methods and products for transfecting cells" was invented by Matthew Angel (Cambridge, Mass.) and Christopher Rohde (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, a...